期刊文献+

系统性红斑狼疮患者激素治疗前后血清骨钙素、TNF-α、IL-8及C3测定 被引量:1

Changes of asteocalcin bone glaprotein propeptide,cell factor and C3 of SLE patients before and after treatment
下载PDF
导出
摘要 目的:探讨系统性红斑狼疮(SLE)患者治疗前后骨钙素(BGP)、细胞因子(TNF-α、IL-8)的水平变化及对免疫功能的影响。方法:采用放免法及酶免法检测40例SLE患者激素治疗前后血清BGP、TNF-α及IL-8含量,采用速率散射比浊法测定补体C3含量。以30例正常体检者作对照。结果:治疗前40例SLE患者BGP水平低于正常对照组,而TNF-α及IL-8水平高于正常对照组(P<0.01),补体C3水平低下。激素治疗后,SLE患者血清BGP、TNF-α、IL-8水平均下降,C3水平升高(P<0.05)。结论:SLE患者经激素治疗后有骨丢失现象,TNF-α、IL-8及补体C3参与SLE疾病过程。 Aim: To investigate the changes of serum levels of bone glaprotein propep tide (BGP) ,TNF-α IL-8 and C3 of lupus erythematosus(SLE) patients before and after hormone treatment. Methods:A total of 40 SLE patients and 30 normal control people were subjected to detect the serum BGP,TNT-α IL-8 by RIA and ELISA, and C3 by immune rate nephelometry. Results:Compared with those of the control, BGP, C3 level of SLE patients were lower, however, TNF-α and IL-8 level were higher. Conclusion:Bone loss exists in SLE patients treated with hormone. TNF-α, C3 and IL-8 are related with the development and activity of SLE.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2008年第2期287-288,共2页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省教育厅自然科学基金资助项目2004312005
关键词 系统性红斑狼疮 骨钙素 细胞因子 免疫功能 SLE bone glaprotein propeptide cell factor immune function
  • 相关文献

参考文献7

  • 1鞠少卿,张冬雷,倪红兵,陈晓栋,孔宪涛,仲人前.B淋巴细胞激活因子及其受体mRNA与系统性红斑狼疮关联性研究[J].临床皮肤科杂志,2006,35(6):348-350. 被引量:3
  • 2Weinstein RS,Jilka RL,Paifitt AM, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and ostewocytes by glucocorticoids [ J ]. J Clint Invest, 1998,102(2) :274.
  • 3杨伟民,邵斌.骨代谢生化指标与骨质疏松症[J].中国骨质疏松杂志,2004,10(1):118-121. 被引量:50
  • 4Balow JE, Austin HA 3rd, Maintenance therapy for lupus nephritis something old, something new [ J ], N Engl J Med, 2004,350(10) :1044.
  • 5Mariette Roux S,Zhang J,Bengoufa D,et al. The level of BlyS (BAFF) correlates with the titres of autoantibodies in human Sjogren's syndrome [ J ]. Ann Rheum Dis ,2003,62 (2) : 162.
  • 6Saisoong S,Eiam-Ong S, Hanvivatcong O. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients[ J]. Clin Exp Rheumatol, 2006,24( 1 ) :51.
  • 7颜廷立.系统性红斑狼疮治疗中骨质丢失的研究[J].医学理论与实践,2005,18(11):1272-1274. 被引量:1

二级参考文献25

  • 1葛雪琳,蔡桂英.骨转换生化标志物与骨质疏松[J].中国骨质疏松杂志,1999,5(2):85-88. 被引量:28
  • 2Saag KG,Emkey R,schnitzer TJ,et al.Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. New Eng J Med,1998,339:292-297.
  • 3Weinstein Rs,et al.Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids.J Clin Invest,1998,102:274.
  • 4Munk A,Guyre PM,Holbrook NK.Physiological function of glucocorticoids in stress and their relation to pharmacological actions.Endocr Rev,2001.48-50.
  • 5Manolagas BC,Weinstein RS.Therapy of glucocorticoid-induced osteoparosis with alfacalcidol/Calcium and vitamin D Calcium.Rheumatol,2000,59:176-179.
  • 6Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator[J]. Science, 1999, 285(5425): 260-263.
  • 7Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease[J]. Nature, 2000, 404(6781): 995-999.
  • 8Stohl W. Systemic lupus erythematosus: a blissless disease of too much BLyS (Blymphocyte stimulator) protein [J]. Curr Opin Rheumatol, 2002, 14(5): 522-528.
  • 9Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome[J]. Ann Rheum Dis, 2003, 62(2): 168-171.
  • 10Krumbholz M, Theil D, Derfuss T, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma [J]. J Exp Med, 2005,201(2): 195-200.

共引文献51

同被引文献11

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部